September 14, 2018
Robert J. Lee, PhD, was recently selected as The Ohio State University College of Pharmacy’s Kimberly Professor of Pharmacy, pending approval by The Ohio State University Board of Trustees. Dr. Lee’s appointment will be effective through August 31, 2021.
The Kimberly Professorship in Pharmacy serves as an honor and reward to an existing full professor in the College of Pharmacy for outstanding scholarly activity and carries a stipend for a three-year period. The criterion for the appointment is scholarship, defined as engagement in advanced study with the acquirement of expert knowledge in a special field.
“We are incredibly pleased to have Dr. Lee assume this important professorship at the College of Pharmacy,” said Henry J. Mann, PharmD, FCCP, FCCM, FASHP, dean and professor at Ohio State’s College of Pharmacy. “Dr. Lee has been a valued and productive member of our college and the Division of Pharmaceutics and Pharmaceutical Chemistry for more than 20 years and he is very deserving of this recognition.”
Dr. Lee’s research focuses on the design and development of novel targeted drug delivery systems for cancer and leukemia therapeutics based on lipid and/or polymer-based nanoparticles. These include novel multifunctional theranostic agents, novel lipid nanoparticle (LNP) formulations of oligonucleotides, including those for antisense oligos, siRNA, antimiRs, and miRNA mimics, novel targeted contrast agents for diagnostic imaging, non-viral vectors for gene therapy, and liposome and nanoparticle-based carriers for chemotherapeutic agents.
Prior to joining Ohio State, Dr. Lee served as the vice president of research and development for Endocyte, Inc., in Lafayette, Indiana and a visiting scientist in the Department of Chemistry at Purdue University.
Dr. Lee earned his bachelor’s degree from Peking University in Beijing, China. He received his PhD under the direction of Dr. Philip S. Low at Purdue University and completed post-doctoral training under the direction of Dr. Leaf Huang at the University of Pittsburgh. In 2015, Dr. Lee was named The Ohio State University Innovator of the Year. In 2006, Dr. Lee received the Highest Cited Original Research Award for his article, Wu, J., Liu, Q., and Lee, R.J. “A folate receptor-targeted liposomal formulation for paclitaxel” from Int. J. Pharm. 316:148-153. Most recently, Dr. Lee received the 2018 Institute of Materials Research (IMR) Innovation Award.